Division of Cardiology and Department of Medicine, University of Maryland, Baltimore, MD 21201, USA.
Circ Heart Fail. 2013 Jan;6(1):118-26. doi: 10.1161/CIRCHEARTFAILURE.112.969576. Epub 2012 Nov 20.
Glucose 6-phosphate dehydrogenase (G6PD) is the most common deficient enzyme in the world. In failing hearts, G6PD is upregulated and generates reduced nicotinamide adenine dinucleotide phosphate (NADPH) that is used by the glutathione pathway to remove reactive oxygen species but also as a substrate by reactive oxygen species-generating enzymes. Therefore, G6PD deficiency might prevent heart failure by decreasing NADPH and reactive oxygen species production.
This hypothesis was evaluated in a mouse model of human G6PD deficiency (G6PDX mice, ≈40% normal activity). Myocardial infarction with 3 months follow-up resulted in left ventricular dilation and dysfunction in both wild-type and G6PDX mice but significantly greater end diastolic volume and wall thinning in G6PDX mice. Similarly, pressure overload induced by transverse aortic constriction (TAC) for 6 weeks caused greater left ventricular dilation in G6PDX mice than wild-type mice. We further stressed transverse aortic constriction mice by feeding a high fructose diet to increase flux through G6PD and reactive oxygen species production and again observed worse left ventricular remodeling and a lower ejection fraction in G6PDX than wild-type mice. Tissue content of lipid peroxidation products was increased in G6PDX mice in response to infarction and aconitase activity was decreased with transverse aortic constriction, suggesting that G6PD deficiency increases myocardial oxidative stress and subsequent damage.
Contrary to our hypothesis, G6PD deficiency increased redox stress in response to infarction or pressure overload. However, we found only a modest acceleration of left ventricular remodeling, suggesting that, in individuals with G6PD deficiency and concurrent hypertension or myocardial infarction, the risk for developing heart failure is higher but limited by compensatory mechanisms.
葡萄糖-6-磷酸脱氢酶(G6PD)是世界上最常见的缺乏酶。在衰竭的心脏中,G6PD 上调并产生还原型烟酰胺腺嘌呤二核苷酸磷酸(NADPH),该物质被谷胱甘肽途径用于清除活性氧,但也被活性氧生成酶用作底物。因此,G6PD 缺乏可能通过减少 NADPH 和活性氧的产生来预防心力衰竭。
在人类 G6PD 缺乏症(G6PDX 小鼠,约正常活性的 40%)的小鼠模型中评估了该假说。心肌梗死并随访 3 个月导致野生型和 G6PDX 小鼠的左心室扩张和功能障碍,但 G6PDX 小鼠的舒张末期容积和壁变薄明显更大。同样,6 周的横主动脉缩窄(TAC)引起的压力超负荷导致 G6PDX 小鼠的左心室扩张大于野生型小鼠。我们进一步通过给予高果糖饮食来增加 G6PD 和活性氧生成的通量来加重 TAC 小鼠的压力超负荷,再次观察到 G6PDX 小鼠的左心室重构更差,射血分数更低。梗塞后 G6PDX 小鼠的组织脂质过氧化产物含量增加,横主动脉缩窄后顺乌头酸酶活性降低,表明 G6PD 缺乏增加了心肌氧化应激和随后的损伤。
与我们的假设相反,G6PD 缺乏症增加了对梗塞或压力超负荷的氧化还原应激。然而,我们仅发现左心室重构略有加速,这表明在 G6PD 缺乏症合并高血压或心肌梗塞的个体中,发生心力衰竭的风险更高,但受到代偿机制的限制。